It is easy, simply RCHA is creating a cure based on something reasonable medically and chemically talking with NO USE OF CHEMOTHERAPY which goes kind of against the business in health sector. Look at DCTH went higher to get up-list to Nasdaq long time ago and have passed most of FDA approval because their liver cancer treatment and other of their products are based on chemotherapy. You could see the difference in attention, product image, investor support, and government allowance. It is important as investor you know in depth company's product and target vision, this company is different to other ones that are skyrocketing because of their products in the cancer industry are the ones convenient to keep business.
